Arcline Investment Management has closed its first investment fund, Arcline Capital Partners LP, with $1.5 billion of committed capital.
Investors in the new fund include university endowments, sovereign wealth funds, family offices and charitable foundations.
“We want to thank our investors for entrusting us with their capital,” said CEO Rajeev Amara. “At Arcline, we hope to continue our team’s historical record of achieving strong returns by investing in competitively differentiated market leaders and partnering with management teams who can create value by driving organic revenue and earnings growth.”
Mr. Amara is a former managing director of Golden Gate Capital. He joined Golden Gate in July 2000 and was active in a variety of industrials sectors, including energy, aerospace, chemicals, building products, distribution, industrial technology, healthcare manufacturing and packaging. Mr. Amara left Golden Gate in September 2018 to form Arcline.
Arcline makes control investments in companies that have up to $100 million of EBITDA and enterprise values of up to $1 billion. Sectors of interest include health and personal care, biopharma and life sciences, food & beverage, packaging, building products, aerospace & defense, and energy. Arcline was founded in September 2018 and has offices in San Francisco and New York (www.arcline.com).
Other members of the Arcline team include President Shyam Ravindran (San Francisco), Partner Luke Johnson (New York), Operating Partner Bruce Sinclair (San Francisco), Operating Partner Neel Bhatia (San Francisco), Vice President Sean Cotter (San Francisco), Vice President Kevin Steiner (San Francisco), and Associate William Tucker Dayton (New York).
Kirkland & Ellis (www.kirkland.com) provided legal services for this fundraise.
© 2019 Private Equity Professional | March 13, 2019